HIV Infection and Risk Related Coinfections/Comorbidities in Indonesia (INAPROACTIVE)
A Prospective Observational Cohort Study on HIV Infection and Risk Related Coinfections/Comorbidities in Indonesia
Sponsor: Ina-Respond
Listed as NCT03663920, this observational or N/A phase trial focuses on HIV and remains completed. Sponsored by Ina-Respond, it has been updated 13 times since 2018, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Aug 2023 — Dec 2023 [monthly]
Active Not Recruiting
-
Apr 2023 — Aug 2023 [monthly]
Active Not Recruiting
▶ Show 8 earlier versions
-
Dec 2021 — Apr 2023 [monthly]
Active Not Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — Aug 2020 [monthly]
Recruiting
-
Apr 2019 — Feb 2020 [monthly]
Recruiting
-
Mar 2019 — Apr 2019 [monthly]
Recruiting
-
Oct 2018 — Mar 2019 [monthly]
Recruiting
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ina-Respond
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Banda Aceh, Indonesia , Bandung, Indonesia , Banjarmasin, Indonesia , Batam, Indonesia , Denpasar, Indonesia , Jakarta, Indonesia , Jayapura, Indonesia , Makassar, Indonesia , Maumere, Indonesia , Medan, Indonesia and 6 more locations